0001209191-19-043397.txt : 20190726 0001209191-19-043397.hdr.sgml : 20190726 20190726172716 ACCESSION NUMBER: 0001209191-19-043397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190613 FILED AS OF DATE: 20190726 DATE AS OF CHANGE: 20190726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAZIMI A J CENTRAL INDEX KEY: 0001075050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 19978767 MAIL ADDRESS: STREET 1: 1207 17TH AVENUE SUITE 103 CITY: NASHVILLE STATE: TN ZIP: 37212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-13 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001075050 KAZIMI A J 2525 WEST END AVE. SUITE 950 NASHVILLE TN 37203 1 1 1 0 Chairman and CEO Common Stock 2019-06-13 4 P 0 60 6.42 A 5762542 D Common Stock 2019-06-14 4 P 0 60 6.37 A 5762602 D Common Stock 2019-06-17 4 P 0 60 6.33 A 5762662 D Common Stock 2019-06-18 4 P 0 60 6.36 A 5762722 D Common Stock 2019-06-19 4 P 0 60 6.35 A 5762782 D Common Stock 2019-06-20 4 P 0 60 6.33 A 5762842 D Common Stock 2019-06-21 4 P 0 60 6.34 A 5762902 D Common Stock 2019-06-24 4 P 0 60 6.54 A 5762962 D Common Stock 2019-06-25 4 P 0 60 6.56 A 5763022 D Common Stock 2019-06-26 4 P 0 60 6.54 A 5763082 D Common Stock 2019-06-27 4 P 0 60 6.48 A 5763142 D Common Stock 2019-06-28 4 P 0 60 6.49 A 5763202 D Common Stock 2019-07-01 4 P 0 60 6.52 A 5763262 D Common Stock 2019-07-02 4 P 0 60 6.49 A 5763322 D Common Stock 2019-07-03 4 P 0 60 6.46 A 5763382 D Common Stock 2019-07-05 4 P 0 60 6.49 A 5763442 D Common Stock 2019-07-08 4 P 0 60 6.37 A 5763502 D Common Stock 2019-07-09 4 P 0 60 6.15 A 5763562 D Common Stock 2019-07-10 4 P 0 60 6.07 A 5763622 D Common Stock 2019-07-11 4 P 0 60 5.93 A 5763682 D Common Stock 2019-07-12 4 P 0 60 6.01 A 5763742 D Common Stock 2019-07-15 4 P 0 60 5.85 A 5763802 D Common Stock 2019-07-16 4 P 0 60 5.88 A 5763862 D Common Stock 2019-07-17 4 P 0 60 5.85 A 5763922 D Common Stock 2019-07-18 4 P 0 60 5.84 A 5763982 D Common Stock 2019-07-19 4 P 0 60 5.69 A 5764042 D Common Stock 2019-07-22 4 P 0 60 5.75 A 5764102 D Common Stock 2019-07-24 4 P 0 60 5.93 A 5764162 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. A.J. Kazimi by /s/ Michael Bonner as attorney-in-fact 2019-07-26